Published in Cell · View the paper (DOI)
Researchers at UNC-Chapel Hill and Stanford solve the high-resolution structure of psychedelic compounds bound to the 5-HT2A serotonin receptor, revealing key insights into their therapeutic potential. The discovery sets the stage for the exploration of more precise compounds with strong therapeutic effects.
Coverage from 2 institutions